paclitaxel has been researched along with T-Cell Lymphoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, K; Chiang, S; Duvic, M; Ensor, J; Hwu, P; Iyer, S; Miranda, R; Pingali, SR; Zu, Y | 1 |
| Li, SZ; Luo, B; Peng, ZG; Shi, ZY; Tang, ZY; Wu, ZG; Yao, YB | 1 |
| Albeck, M; Danoch, H; Kalechman, Y; Longo, DL; Sredni, B | 1 |
| Etrych, T; Ríhová, B; Sírová, M; Starovoytova, L; Ulbrich, K | 1 |
| Danielová, V; Ehrlichová, M; Gut, I; Holubová, J; Horský, S; Otová, B; Simek, P; Soucek, P; Václavíková, R | 1 |
| De Baetselier, P; De Braekeleer, J; Dewit, J; Schirrmacher, V; Verschueren, H | 1 |
| Gartenhaus, RB; Herbert, GB; Shi, B | 1 |
1 review(s) available for paclitaxel and T-Cell Lymphoma
| Article | Year |
|---|---|
T-cell lymphoma secondary to checkpoint inhibitor therapy.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Humans; Immunotherapy; Lymphoma, T-Cell; Male; Neoplasms, Second Primary; Paclitaxel; Pleural Neoplasms; Prognosis; Urinary Bladder Neoplasms | 2020 |
6 other study(ies) available for paclitaxel and T-Cell Lymphoma
| Article | Year |
|---|---|
[Exploring the Mechanism of Paclitaxel Inhibiting T-cell Lymphoma based on High-throughput Sequencing and Public Databases].
Topics: Computational Biology; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing; Humans; Lymphoma, T-Cell; Paclitaxel; Reproducibility of Results | 2021 |
Sensitizing B- and T- cell Lymphoma Cells to Paclitaxel/Abraxane-Induced Death by AS101 via Inhibition of the VLA-4-IL10-Survivin Axis.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Ethylenes; Humans; Inhibitor of Apoptosis Proteins; Integrin alpha4beta1; Interleukin-10; Lymphoma, B-Cell; Lymphoma, T-Cell; Mice; Neoplasm Transplantation; Paclitaxel; Repressor Proteins; Signal Transduction; Survivin | 2015 |
HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Docetaxel; Hydrogen-Ion Concentration; Lymphoma, T-Cell; Male; Methacrylates; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Paclitaxel; Polymers; Taxoids | 2010 |
Effects of paclitaxel, docetaxel and their combinations on subcutaneous lymphomas in inbred Sprague-Dawley/Cub rats.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Body Weight; Cell Line, Tumor; Docetaxel; Drug Therapy, Combination; Gene Expression Regulation; Humans; Intestinal Mucosa; Lymphoma, T-Cell; Mice; Microsomes, Liver; Paclitaxel; Rats; Rats, Sprague-Dawley; Subcutaneous Tissue; Taxoids | 2006 |
Motility and invasive potency of murine T-lymphoma cells: effect of microtubule inhibitors.
Topics: Animals; Cell Movement; Fibroblasts; Fourier Analysis; Leukemia L5178; Lymphoma, T-Cell; Mice; Mice, Inbred DBA; Microtubules; Neoplasm Invasiveness; Nocodazole; Paclitaxel; Tumor Cells, Cultured | 1994 |
Expression and stabilization of the MCT-1 protein by DNA damaging agents.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Cell Cycle; Cell Cycle Proteins; Cell Nucleus; Cyclin D1; Cytoplasm; DNA Damage; Doxorubicin; G1 Phase; Gene Expression Regulation, Neoplastic; Hot Temperature; Humans; Immunoblotting; Jurkat Cells; Lymphoma, T-Cell; Mice; Oncogene Proteins; Paclitaxel; RNA, Messenger; S Phase; Subcellular Fractions; Time Factors; X Chromosome | 2001 |